Perz, J. B., S. O. Schonland, M. Hundemer, A. V. Kristen, T. J. Dengler, M. Zeier, R. P. Linke, A. D. Ho and H. Goldschmidt: High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. In: British Journal of Haematology 127, 5, 543-551 (2004).
Perz, J. B., S. Schoenland, M. Hundemer, R. P. Linke, A. D. Ho and H. Goldschmidt: High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis. In: Bone Marrow Transplantation 33, Suppl. Suppl. 1, S159-S159 (2004).
Zeier, M., J. Perz, R. P. Linke, U. Donini, R. Waldherr, K. Andrassy, A. D. Ho and H. Goldschmidt: No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. In: Nephrology Dialysis Transplantation 18, 12, 2644-2647 (2003).
Zeier, M., J. Perz, R. Linke, U. Donini, R. Waldherr, A. D. Ho and H. Goldschmidt: Persistence of glomerular amyloid after autologous blood stem cell transplantation in Al-amyloidosis despite remission of nephrotic syndrome.. In: Journal of the American Society of Nephrology 13, Suppl. S, 469A-470A (2002).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.